Glover v. Connecticut General Life Insurance Company

CourtDistrict Court, D. Connecticut
DecidedSeptember 4, 2024
Docket3:16-cv-00827
StatusUnknown

This text of Glover v. Connecticut General Life Insurance Company (Glover v. Connecticut General Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glover v. Connecticut General Life Insurance Company, (D. Conn. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

PAULETTE T. GLOVER and JOHN T.

WAREHIME, on behalf of themselves and all others

similarly situated,

Plaintiffs,

v. No. 3:16-cv-00827 (MPS) CONNECTICUT GENERAL LIFE INSURANCE COMPANY, and THE LINCOLN NATIONAL LIFE INSURANCE COMPANY, Defendants.

RULING ON MOTION FOR PRELIMINARY APPROVAL, MOTION TO INTERVENE, AND MOTION TO SEAL This case, involving an alleged breach of life insurance policy provisions governing “cost of insurance” deductions from the investment portion of the policy, has been pending for over eight years. With the defendants’ consent, the plaintiffs now seek an order preliminarily approving a proposed class action settlement and permitting issuance of notice to the settlement class. But three members of the proposed class, Vida Longevity Fund, LP, TVPX ARS Inc., and Jean Heckman (the “Objectors”), oppose the settlement and have filed a motion to intervene. All three Objectors are court-appointed class representatives or proposed class representatives in other federal lawsuits involving life insurance policies that were either issued or administered by Defendant Lincoln National Life Insurance Company: TVPX ARS Inc. v. Lincoln Life Insurance Co., No. 2:18-cv- 02989-RBS (E.D. Pa.) (“TVPX”), Iwanski v. First Penn-Pacific Life Insurance Co., No. 2:18-cv- 01573-RBS (E.D. Pa.) (“Iwanski”), and Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, No. 1:19-cv-06004-ALC-VF (S.D.N.Y.) (“Vida Longevity Fund”). The Court assumes familiarity with the parties’ submissions, the July 30, 2024 oral argument, and the record. For the reasons set forth below, I deny the motion to intervene as moot and grant the motion for preliminary approval of the settlement. I also deny without prejudice the Objectors’ motion to seal their opposition memorandum and exhibits.

I. MOTION TO INTERVENE

The Objectors have filed a motion to intervene, ECF No. 254, which notes that the Objectors have “standing to object to preliminary approval of the proposed settlement even absent intervention,” because they are “members of the proposed . . . settlement class.” ECF No. 254 at 6. At oral argument the parties agreed that the Objectors have standing to object to preliminary approval. ECF No. 288 at 6; see also ECF No. 254 at 6 (noting that “Lincoln agreed on a meet- and-confer . . . that proposed intervenors have standing to object . . . .). Because the Objectors do not need to intervene in this lawsuit to object to preliminary approval of the settlement, the motion to intervene is denied as moot. II. MOTION FOR PRELIMINARY APPROVAL

The plaintiffs have moved for preliminary approval of a proposed settlement between the defendants and the following class of plaintiffs: All persons who own or owned a life insurance policy, that was active on or after May 27, 2010, and was issued or administered by either Defendant, or their predecessors in interest, the terms of which provide or provided for: 1) a cost of insurance charge calculated using a rate that is determined based on expectations as to future mortality experience; 2) additional but separate policy charges, deductions, or expenses; 3) an investment, interest-bearing, or savings component; and 4) a death benefit.

ECF No. 226 ¶ 5. Under Rule 23(e), “[t]he claims, issues, or defenses of . . . [a proposed class] . . . may be settled, voluntarily dismissed, or compromised only with the court’s approval.” I may give preliminary approval of the settlement only if I determine that I “will likely be able to: (i) approve the proposal under Rule 23(e)(2); and (ii) certify the class for purposes of judgment on the proposal.” Fed. R. Civ. P. 23(e)(1)(B). Thus, I must consider whether the proposed settlement is likely “fair, reasonable and adequate” under the factors set forth in Rule 23(e)(2), and “ensure that

the settlement class, as defined by the parties, is certifiable under the standards of Rule 23(a) and (b).” Edwards v. N. Am. Power & Gas, LLC, No. 3:14-CV-01714 (VAB), 2018 WL 1582509, at *4 (D. Conn. Mar. 30, 2018) (internal alterations and quotation marks omitted). Further, under Article III of the Constitution, the class representatives must have “standing to assert both [their] individual claims and the class claims brought on behalf of the putative class.” In re Veon Ltd. Sec. Litig., No. 15-CV-08672 (ALC), 2021 WL 930478, at *6 (S.D.N.Y. Mar. 11, 2021). The Objectors argue that the Court should deny preliminary approval of the proposed class settlement in this case because (1) the plaintiffs lack class standing to raise claims on behalf of the Objectors, (2) the proposed class cannot be certified under Rule 23(a) because the class representatives do not have typical claims and are not adequate representatives of the proposed

class, (3) the proposed settlement is unfair, unreasonable, and inadequate, and (4) the proposed notice would be confusing to members of the already-certified class in the Vida Longevity Fund litigation in the Southern District of New York. For the reasons explained below, I disagree and grant the motion for preliminary approval of the class. A. Class Standing The Objectors argue that Plaintiff Paulette Glover “does not have class standing to assert claims against Lincoln products, given that Glover only owns a Connecticut general policy.” ECF No. 256 at 36. And they claim that Plaintiff John Warehime was not properly added to this case because the amendment naming him as a plaintiff was filed after the amendment deadline in the scheduling order. Therefore, they assert, “class standing should be evaluated only for Glover.” Id. at 36-37. As a preliminary matter, I agree with the Objectors that the plaintiffs could not amend their complaint to add Warehime without good cause. The Court notified the parties that “[a]ny

amendments to the Complaint [were] due by November 20, 2023.” ECF No. 221. On March 8, 2024, the plaintiffs filed their amended complaint with the consent of the defendants but without seeking leave of Court. ECF No. 226. “[T]he Rule 16(b) ‘good cause’ standard, rather than the more liberal standard of Rule 15(a), governs a motion to amend filed after the deadline a district court has set for amending the pleadings.” Parker v. Columbia Pictures Indus., 204 F.3d 326, 340 (2d Cir. 2000). Thus, the plaintiffs could amend their complaint to add Warehime “only for good cause and with the judge’s consent.” Fed. R. Civ. P. 16(b)(4). I nevertheless give the plaintiffs leave, nunc pro tunc, to file their amended complaint, because I find that the amendment is supported by good cause. Adding Warehime will facilitate resolution of this action through class settlement and thereby spare the parties time and expense.

So I consider Warehime’s claims in evaluating whether the named plaintiffs have Article III standing to assert claims on behalf of the entire class. “[I]n a putative class action, a plaintiff has class standing if he [or she] plausibly alleges (1) that he [or she] personally has suffered some actual injury as a result of the putatively illegal conduct of the defendant, and (2) that such conduct implicates the same set of concerns as the conduct alleged to have caused injury to other members of the putative class by the same defendants.” NECA-IBEW Health & Welfare Fund v. Goldman Sachs & Co., 693 F.3d 145, 162 (2d Cir. 2012) (internal citations, quotation marks, and alterations omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Carver v. City of New York
621 F.3d 221 (Second Circuit, 2010)
Mahon v. Ticor Title Insurance Company
683 F.3d 59 (Second Circuit, 2012)
In Re Flag Telecom Holdings Securities Litigation
574 F.3d 29 (Second Circuit, 2009)
Collado v. City of New York
193 F. Supp. 3d 286 (S.D. New York, 2016)
Alexander v. Azar
370 F. Supp. 3d 302 (D. Connecticut, 2019)
Morris v. Affinity Health Plan, Inc.
859 F. Supp. 2d 611 (S.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Glover v. Connecticut General Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glover-v-connecticut-general-life-insurance-company-ctd-2024.